Erin Reid - Concepedia

Author

Erin Reid

University of California San Diego ORCID

Also Known As

E. G. Reid, E. Reid, E.G. Reid, Eloa Reid, Erin S Reid, Erin G Reid, Erin G. Reid, Erin Gourley Reid, Erin Reid, Erin S Reid

136

Publications

2.9K

Citations

H-Index

Concepts

All Affiliations

University of California San Diego Memorial Sloan Kettering Cancer Center The University of Texas MD Anderson Cancer Center Johns Hopkins University Washington University in St. Louis

About

Erin Reid is an author at University of California San Diego specializing in medicine, immunology, and immunotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	13	732
2	Cellular Therapies	3	3	199
3	Arts	1	1	15
4	Engineering	1	1	12
5	Health Sciences	1	1	15

Erin Reid

Publications

2.6K

Citations

H-Index

Page 1

	Year	Citations
NCCN Guidelines Insights: B-Cell Lymphomas, Version 3.2019 Andrew D. Zelenetz, Leo I. Gordon, Jeremy S. Abramson, Journal of the National Comprehensive Cancer Network	2019	186
Non-Hodgkin’s Lymphomas, Version 4.2014 Andrew D. Zelenetz, Leo I. Gordon, William G. Wierda, Journal of the National Comprehensive Cancer Network	2014	169
Final results of a phase 1 study of loncastuximab tesirine in relapsed/refractory B-cell non-Hodgkin lymphoma Mehdi Hamadani, John Radford, Carmelo Carlo‐Stella, Blood	2020	165
NCCN Guidelines® Insights: B-Cell Lymphomas, Version 5.2021 Andrew D. Zelenetz, Leo I. Gordon, Julie Chang, Journal of the National Comprehensive Cancer Network Hematological MalignancyNccn Guidelines® InsightsLymphoid NeoplasiaNovel TherapyMantle Cell Lymphoma	2021	164
NCCN Guidelines Insights: Non-Hodgkin's Lymphomas, Version 3.2016 Steven M. Horwitz, Andrew D. Zelenetz, Leo I. Gordon, Journal of the National Comprehensive Cancer Network Cell TherapyCancer ManagementImmunologyNccn Guidelines InsightsPathology	2016	140
Phase II Trial of Imatinib in AIDS-Associated Kaposi's Sarcoma: AIDS Malignancy Consortium Protocol 042 Henry Koon, Susan E. Krown, Jeannette Y. Lee, Journal of Clinical Oncology	2013	107
Cancer in People Living With HIV, Version 1.2018, NCCN Clinical Practice Guidelines in Oncology Erin Reid, Gita Suneja, Richard F. Ambinder, Journal of the National Comprehensive Cancer Network	2018	103
A Phase I Study of ADCT-402 (Loncastuximab Tesirine), a Novel Pyrrolobenzodiazepine-Based Antibody–Drug Conjugate, in Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma Brad S. Kahl, Mehdi Hamadani, John Radford, Clinical Cancer Research	2019	102
NCCN Guidelines® Insights: B-Cell Lymphomas, Version 6.2023 Andrew D. Zelenetz, Leo I. Gordon, Jeremy S. Abramson, Journal of the National Comprehensive Cancer Network	2023	100
AMC 048: modified CODOX-M/IVAC-rituximab is safe and effective for HIV-associated Burkitt lymphoma Ariela Noy, Jeannette Y. Lee, Ethel Cesarman, Blood	2015	98

Page 1